Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2829-2835

  McColl, Shaun R ^a   Clark Lewis, Ian ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; MACROPHAGE INFLAMMATORY PROTEIN 2; RECEPTOR BLOCKING AGENT; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; EXTRAVASATION; GROWTH RELATED ONCOGENE ALPHA; LEUKOCYTE MIGRATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; ONCOGENE; PERITONEAL CAVITY; PRIORITY JOURNAL;

ANIMALS; CELL MIGRATION INHIBITION; CELL MOVEMENT; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; DIFFUSION CHAMBERS, CULTURE; GROWTH SUBSTANCES; IMMUNE SERA; IMMUNIZATION, PASSIVE; INJECTIONS, INTRAPERITONEAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; MONOKINES; NEUTROPHILS; PEPTIDE FRAGMENTS; PERITONITIS; PLATELET FACTOR 4; RECEPTORS, CHEMOKINE;

EID: 0033198103     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
2. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
3. Samuelsson, B., S. V. Dahlen, J. A Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171.
4. Gerard, C., and N. P. Gerard. 1994. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775.
5. Devery, J. M., N. J. King, and C. L. Geczy. 1994. Acute inflammatory activity of the S100 protein CP-10: activation of neutrophils in vivo and in vitro. J. Immunol. 152:1888.
6. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
7. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
8. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395.
9. Bazan, J. F., K. B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D. R. Greaves, A. Zlotnik, and T. J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640.
10. Pan, Y., C. Lloyd, H. Zhou, S. Dolich, J. Deeds, J. A. Gonzalo, J. Vath, M. Gosselin, J. Y. Ma, B. Dussault, E. Woolf, G. Alperin, J. Culpepper, J. Carlos Gutierrez-Ramos, and D. Gearing. 1997. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611.
11. Clark-Lewis, I., K. S. Kim, K. Rajarathnam, J. H. Gong, B. Dewald, B. Moser, M. Baggiolini, and B. D. Sykes. 1995. Structure-activity relationships of chemokines. J. Leukocyte Biol. 57:703.
12. 2-terminal residues. J. Exp. Med. 181:631.
13. Gong, J. H., M. Uguccioni, B. Dewald, M. Baggiolini, and I. Clark-Lewis. 1996. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J. Biol. Chem. 271:10521.
14. Proudfoot, A. E., C. A. Power, A. J. Hoogewerf, M. O. Montjovent, F. Borlat, R. E. Offord, and T. N. Wells. 1996. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. 271:2599.
15. Arenzana-Seisdedos, F., J. L. Virelizier, D. Roussel, I. Clark-Lewis, P. Loetscher, B. Moser, and M. Baggiolini. 1996. HIV blocked by a chemokine antagonist. Nature 383:400.
16. Simmons, G., P. R. Clapham, L. Picard, R. E. Offord, M. M. Rosenkilde, T. W. Schwartz, R. Buser, T. N. C. Wells, and A. E. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276.
17. Gong, J. H., L. G. Ratkay, J. D. Waterfield, and I. Clark-Lewis. 1997. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 186:131.
18. Platerzyberk, C., A. J. Hoogewerf, A. E. I. Proudfoot, C. A. Power, and T. N. C. Wells. 1997. Effect of a C C chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 57:117.
19. Moser, B., B. Dewald, L. Barella, C. Schumacher, M. Baggiolini, and I. Clark-Lewis. 1993. Interleukin-8 antagonists generated by N-terminal modification. J. Biol. Chem. 268:7125.
20. Clark-Lewis, I., B. Dewald, M. Loetscher, B. Moser, and M. Baggiolini. 1994. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J. Biol. Chem. 269:16075.
21. Jones, S. A., B. Dewald, I. Clark-Lewis, and M. Baggiolini. 1997. Chemokine antagonists that discriminate between interleukin-8 receptors: selective blockers Of CXCR2. J Biol. Chem. 272:16166.
22. Cacalano, G., J. Lee, K. Kikly, A. M. Ryan, S. Pitts Meek, B. Hultgren, W. I. Wood, and M. W. Moore. 1994. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265:682.
23. Tessier, P. A., P. H. Naccache, I. Clark-Lewis, R. P. Gladue, K. S. Neote, and S. R. McColl. 1997. Chemokine networks in vivo: involvement of both C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNFα. J. Immunol. 19:3595.
24. Morona, R., M. H. Brown, J. Yeadon, M. W. Heuzenroeder, and P. A. Manning. 1991. Effect of lipopolysaccharide core synthesis mutations on the production of Vibrio cholerae O-antigen in Escherichia coli K-12. FEMS Microbiol. Lett. 66: 279.
25. McColl, S. R., and P. H. Naccache. 1997. Calcium mobilization assays. Methods Enzymol. 288:301.
26. L'Heureux, G. P., S. Bourgoin, N. Jean, S. R. McColl, and P. H. Naccache. 1995. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO-α, stimulates phospholipase D activity. Blood 85:522.
27. Damaj, B. B., S. R. McColl, K. Neote, C. A. Hebert, and P. H. Naccache. 1996. Diverging signal transduction pathways activated by interleukin 8 (IL-8) and related chemokines in human neutrophils: IL-8 and Gro-α differentially stimulate calcium influx through IL-8 receptors A and B. J. Biol. Chem. 271:20540.
28. Jones, S. A., M. Wolf, S. Qin, C. R. Mackay, and M. Baggiolini. 1996. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci. USA 93:6682.
29. Bozic, C. R., L. F. Kolakowski, Jr., N. P. Gerard, C. Garcia Rodriguez, C. von Uexkull Guldenband, M. J. Conklyn, R. Breslow, H. J. Showell, and C. Gerard. 1995. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154:6048.
30. Wolpe, S. D., and A. Cerami. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 3:2565.
31. Standiford, T. J., S. L. Kunkel, N. W. Lukacs, M. J. Greenberger, J. M. Danforth, R. G. Kunkel, and R. M. Stricter. 1995. Macrophage inflammatory protein-1α mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155:1515.
32. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959.
33. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97.